Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Cancers (Basel) ; 12(6)2020 Jun 18.
Article in English | MEDLINE | ID: mdl-32570974

ABSTRACT

Adolescents and young adults (AYAs) represent a distinct group of patients. The objectives of this study were: To compare adolescent prognosis to that of younger children; to compare the results achieved with the two consecutive protocols in both age groups; to analyze clinical characteristics of children and adolescents. Between 1996 and 2017, 1759 patients aged <18 years were evaluable for the study. Five hundred and sixty patients were treated with the MH'96 protocol and 1199 with the LH2004 protocol. Four hundred and eighty-two were adolescents aged ≥15 years. Patients in both age groups showed very favorable prognoses. In particular, OS improved with the LH2004 protocol, especially in the adolescent group and in the low risk group, where radiation therapy was spared. Adolescent characteristics differed significantly from the children's according to sex, histology, and the presence of symptoms. Remarkable is the decrease both in mixed cellularity in the children and in low stages in both age groups in the LH2004 protocol with respect to MH'96 protocol. Based on our experience, adopting pediatric protocols for AYA does not compromise patient outcomes.

2.
Thromb Haemost ; 113(6): 1270-7, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25761414

ABSTRACT

Data from large case series of children with cerebral thrombotic events are pivotal to improve prevention, early recognition and treatment of these conditions. The Italian Registry of Pediatric Thrombosis (R. I. T. I.) was established in 2007 by a multidisciplinary team, aiming for a better understanding of neonatal and paediatric thrombotic events in Italy and providing a preliminary source of data for the future development of specific clinical trials and diagnostic-therapeutic protocols. We analysed data relative to the paediatric cerebral thrombotic events of the R. I. T. I. which occurred between January 2007 and June 2012. In the study period, 79 arterial ischaemic stroke (AIS) events (49 in males) and 91 cerebral sinovenous thrombosis (CSVT) events (65 in males) were enrolled in the R. I. T. I. Mean age at onset was 4.5 years in AIS, and 7.1 years in CSVT. Most common modes of presentation were hemiparesis, seizures and speech disturbances in AIS, and headache, seizures and lethargy in CSVT. Most common etiologies were underlying chronic diseases, vasculopathy and cardiopathy in AIS, and underlying chronic diseases and infection in CSVT. Time to diagnosis exceeded 24 hours in 46 % AIS and 59 % CSVT. Overall data from the Italian Registry are in substantial agreement with those from the literature, despite small differences. Among these, a longer time to diagnosis compared to other registries and case series poses the accent to the need of an earlier recognition of paediatric cerebrovascular events in Italy, in order to enable prompt and effective treatment strategies.


Subject(s)
Brain Ischemia/epidemiology , Cerebral Arterial Diseases/epidemiology , Sinus Thrombosis, Intracranial/epidemiology , Stroke/epidemiology , Adolescent , Age of Onset , Brain Ischemia/diagnosis , Brain Ischemia/therapy , Cerebral Arterial Diseases/diagnosis , Cerebral Arterial Diseases/therapy , Child , Child, Preschool , Delayed Diagnosis , Female , Humans , Infant , Italy/epidemiology , Male , Predictive Value of Tests , Recurrence , Registries , Risk Factors , Sinus Thrombosis, Intracranial/diagnosis , Sinus Thrombosis, Intracranial/therapy , Stroke/diagnosis , Stroke/therapy , Time Factors , Treatment Outcome
3.
J Pediatr Surg ; 47(6): e31-40, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22703822

ABSTRACT

Perivascular epithelioid cell tumors (PEComas) include different morphological entities originating from perivascular epithelioid cells. Their clinical behavior is not predictable, and there are no strict histologic criteria for malignancy, although larger tumors with infiltrative growth, hypercellularity, cellular atypia, atypical mitoses, and necrosis generally have a malignant course. Pediatric PEComas are rare, with less than 40 cases reported, mostly in children older than 5 years. We describe a case of malignant PEComa of the ligamentum teres in a 2-year-old girl, characterized by the occurrence of local relapse after primary treatment with chemotherapy and surgery and poor response to imatinib mesilate and temsirolimus used after further analyses confirmed p70S6K expression involved in the mTOR pathway. The girl was eventually treated with a debulking surgical procedure and is now alive with disease 6 years after diagnosis. Literature data of children affected by PEComas were also analyzed, trying to identify pathologic characteristics that could predict their course and therapeutic options. Histologically, they may be differentiated in 3 prognostic categories: (1) benign, lacking unfavorable morphological markers; (2) with uncertain malignant potential, carrying 1 unfavorable marker; and (3) malignant, with at least 2 unfavorable markers. In the literature, 9% of cases occurred as a second malignancy probably because of genomic instability related to treatment. Their different biology and the potential value of targeted therapies remain to be explored. The indolent evolution in our patient was similar to that reported in some other cases in the literature. In terms of treatment, the present case suggests a minor response to temsirolimus compared with the adult population.


Subject(s)
Abdominal Neoplasms/surgery , Ligaments/pathology , Perivascular Epithelioid Cell Neoplasms/surgery , Abdominal Neoplasms/diagnosis , Abdominal Neoplasms/diagnostic imaging , Abdominal Neoplasms/drug therapy , Abdominal Neoplasms/pathology , Antineoplastic Agents/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Benzamides , Biopsy , Child, Preschool , Combined Modality Therapy , Diagnostic Errors , Etoposide/administration & dosage , Female , Humans , Imatinib Mesylate , Intestinal Obstruction/etiology , Ligaments/surgery , Liver Neoplasms/drug therapy , Liver Neoplasms/secondary , Neoplasm Recurrence, Local , Peritoneal Neoplasms/secondary , Peritoneal Neoplasms/surgery , Perivascular Epithelioid Cell Neoplasms/diagnosis , Perivascular Epithelioid Cell Neoplasms/diagnostic imaging , Perivascular Epithelioid Cell Neoplasms/drug therapy , Perivascular Epithelioid Cell Neoplasms/pathology , Perivascular Epithelioid Cell Neoplasms/secondary , Piperazines/therapeutic use , Protein Kinase Inhibitors/therapeutic use , Pyrimidines/therapeutic use , Radiography , Sarcoma, Clear Cell/diagnosis , Sirolimus/administration & dosage , X Chromosome Inactivation
5.
Leuk Lymphoma ; 52(6): 1049-54, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21534870

ABSTRACT

Neurological symptoms can represent the first clinical manifestation of central nervous system (CNS) involvement in Hodgkin lymphoma (HL). Because of its rarity, it is often misunderstood for other pathological processes. We report two cases of pediatric CNS HL, presenting with neurological symptoms at diagnosis. We have also reviewed the literature and few cases are reported, only 19 of them concerning children. In both primary and metastatic CNS HL, all patients complained of neurological symptoms at presentation. Despite it being uncommon, physicians should regard the possibility of CNS localization in all children affected by HL presenting with neurological signs and/or symptoms.


Subject(s)
Central Nervous System/pathology , Hodgkin Disease/diagnosis , Adolescent , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Central Nervous System/drug effects , Central Nervous System/radiation effects , Child , Combined Modality Therapy , Diagnosis, Differential , Female , Hematology/methods , Hodgkin Disease/drug therapy , Hodgkin Disease/radiotherapy , Humans , Italy , Medical Oncology/methods , Radiotherapy/methods , Treatment Outcome
6.
Neuropathology ; 29(5): 574-8, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19077041

ABSTRACT

Cerebral and spinal location of glioneuronal tumors have been recently described as a novel type of primary CNS neoplasia. A distinctive rare form of glioneuronal tumors with neuropil-like islands (GTNI) have been reported to occur in the adult cerebrum, whereas spinal GTNI localization is extremely rare. In the present report we describe a case of a 15-month-old child with a spinal GTNI of the cervical region and meningeal dissemination. Histologically the tumor was composed of round, small neurocytic-like cells arranged around eosinophilic neuropil cores and embedded in a diffuse fibrillar glial component forming prominent "rosetted" neuropil islands displaying strong immunoreactivity for neuronal markers. Cerebral GTNI shows abundant glial components not rarely exhibiting anaplastic features that justify their inclusion within the group of diffuse astrocytomas. In contrast, including our case, spinal GTNI do not show histological evidence of anaplastic features and exhibits a significant neuronal component that may imply considering these lesions in a separate group. Nevertheless, due to their exceptional rarity, the natural history of these lesions is not yet fully understood, but spinal GTNI seems to have an unfavorable clinical course despite their benign histopathological features, which must be taken into account for appropriate treatment and follow-up of the patient.


Subject(s)
Brain Neoplasms/secondary , Meningeal Neoplasms/secondary , Neoplasms, Nerve Tissue/pathology , Spinal Neoplasms/pathology , Brain Neoplasms/pathology , Brain Neoplasms/therapy , Cervical Vertebrae , Fatal Outcome , Humans , Infant , Magnetic Resonance Imaging , Male , Meningeal Neoplasms/pathology , Meningeal Neoplasms/therapy , Neoplasms, Nerve Tissue/therapy , Spinal Neoplasms/therapy
7.
Curr Opin Clin Nutr Metab Care ; 5(3): 309-14, 2002 May.
Article in English | MEDLINE | ID: mdl-11953657

ABSTRACT

In this review the current status of home parenteral nutrition is analysed, with respect to the predictability of weaning from nutritional support and the risk of developing major complications associated with the technique, the loss of vascular access and liver disease. These two complications were evaluated because they represent the more important indication for intestinal transplantation, the availability of which has changed the perspectives of patients and of physicians. Analysis of outcomes from the largest series allows the identification of patients who could be weaned from parenteral nutrition. Important prognostic factors in patients affected by short bowel syndrome are the length and type of the remnant and the time to tolerate enteral feeding. The main complications of therapy are sepsis, thrombosis, nutrient imbalances and liver disease. Sepsis and thrombosis could lead to line replacement and the loss of vascular access. Sepsis no longer represents a major cause of death, but it is a frequent complication. In some patients, it is difficult to assess the risk factors for sepsis, which is possibly related to a poorer outcome. The care of gut failure appears to be the best preventative measure for the occurrence of cholestatic liver disease, but further studies are needed to define the eventual role of lipid emulsion and of specific nutrient deficiency. The quality of life still remains to be studied: because home parenteral nutrition in children has a longer duration, its analysis is mandatory.


Subject(s)
Parenteral Nutrition, Home/adverse effects , Short Bowel Syndrome/therapy , Child , Humans , Liver Diseases/etiology , Liver Diseases/mortality , Parenteral Nutrition, Home/methods , Parenteral Nutrition, Home/standards , Prognosis , Quality of Life , Sepsis/etiology , Sepsis/mortality , Short Bowel Syndrome/complications , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...